IGENOMIX UK is a company that has positioned itself as a pioneer in Reproductive Genetics, establishing expertise in providing advanced services in this field. With a strong history of research & development and a broad experience, the company has emerged as a global leader. Utilizing cutting-edge technology, IGENOMIX UK offers an array of services including embryo testing (PGS/PGD), endometrial receptivity and microbiome analysis (ERA, EMMA, ALICE), carrier screening (CGT), and their highly-regarded non-invasive prenatal test (NACE). The company, headquartered in the United Kingdom, has not disclosed its founding date or its last investment round and participating investors.
There is no investment information
No recent news or press coverage available for Vitrolife & Igenomix Europe, Part of Vitrolife Group.